Hypertension in Germany

Hannelore Neuhauser(Robert Koch Institute), Marcus Dörr(University of Freiburg), Claudia Diederichs(University of Münster), Cornelia Weikert(Federal Institute for Risk Assessment), Roberto Lorbeer(LMU Klinikum), Claus Jünger(Johannes Gutenberg University Mainz), Stephan B. Felix(Universitätsmedizin Greifswald), Annette Peters(Zimmer Biomet (Netherlands)), Henry Völzke(Universitätsmedizin Greifswald), Heiner Boeing(German Institute of Human Nutrition), Philipp S. Wild(Johannes Gutenberg University Mainz)

Deutsches Ärzteblatt international

December 2, 2016

10.3238/arztebl.2016.0809

Cited by 42

Related Papers

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

|The Lancet|2021|3.8k

Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

|European Heart Journal|2013|3.4k

Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants

|The Lancet|2016|2.7k

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

|European Heart Journal|2021|1.7k

Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE project

|The Lancet|2013|1.4k